Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells

Blood

Volumn 113, Issue 3, 2009, Pages 604-611

  Tabaa, Yassine Al ^a   Tuaillon, Edouard ^a   Bollore, Karine ^a   Foulongne, Vincent ^a   Petitjean, Gael ^a   Seigneurin, Jean Marie ^b   Duperray, Christophe ^c   Desgranges, Claude ^c,d   Vendrell, Jean Pierre ^a,c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

^c INSERM   (France)

^d INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; GP350 PROTEIN; IMMUNOGLOBULIN D; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG; BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; TRANSACTIVATOR PROTEIN; VIRUS DNA;

ARTICLE; B LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MEMORY CELL; PERIPHERAL LYMPHOCYTE; PLASMA CELL; PRIORITY JOURNAL; ADULT; CELL CULTURE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; VIROLOGY; VIRUS ACTIVATION; VIRUS INFECTION; VIRUS LATENCY;

ADULT; ANTIGENS, CD27; B-LYMPHOCYTES; CELLS, CULTURED; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; PLASMA CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 60249098317     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-136903     Document Type: Article

References (59)

1. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968; 59:94-101.
2. Thorley-Lawson DA. Epstein-Barr virus. In: Austen KF, Franck MM, Atkinson JP, Canto H, eds. Sampter's Immunologic Diseases. Vol 2. New York, NY: Williams and Wilkins; 2001:970-985.
3. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Virology. Vol 2. New York, NY: Williams and Wilkins; 2001:2575-2628.
4. Kanegane H, Nomura K, Miyawaki T, Tosato G. Biological aspects of Epstein-Barr virus (EBV)- infected lymphocytes in chronic active EBV infection and associated malignancies. Crit Rev Oncol Hematol. 2002;44:239-249.
5. Stevens SJ, Verschuuren EA, Pronk I, et al. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood. 2001;97: 1165-1171.
6. Navarro WH, Kaplan LD. AIDS-related lymphoproliferative disease. Blood. 2006;107:13-20.
7. Petgel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR, Thorley-Lawson DA. Epstein-Barr-Virus- encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol. 2005; 79:15430-15442.
8. Chêne A, Donati D, Guerreiro-Cacais AO, et al. A molecular link between Malaria and Epstein-Barr virus reactivation. PloS Pathogens. 2007;3:826-834.
9. Thorley-Lawson DA, Duca KA. Pathogens cooperate in lymphomagenesis. Nat Med. 2007;13: 906-907.
10. Takada K, Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol. 1989;63:445-449.
11. Sinclair AJ, Brimmell M, Shanahan F, Farell PJ. Pathways of activation of the Epstein-Barr virus. J Virol. 1991;65:2237-2244.
12. Schelcher C, Valencia S, Delecluse HJ, Hicks M, Sinclair AJ. Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV latency. J Virol. 2005; 79:13822-13828.
13. Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J Virol. 2007;81:1037-1042.
14. Speck SH, Chatila T, Flemington E. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 1997;5:399-405.
15. Hummel M, Thorley-Lawson D, Kieff E. An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200). J Virol. 1984;49: 413-417.
16. Kieff E, Rickinson AB. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, eds. Fields Virology. Vol 2. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:2541-2548.
17. Golden HD, Chang RS, Prescott W, Simpson E, Cooper TY. Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis. 1973;127:471-473.
18. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity. 1998;9:395-404.
19. Laichalk LL, Thorley-Lawson DA. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol. 2005; 79:1296-1307.
20. Bachmann MF, Kundig TM, Odermatt B, Hengartner H, Zinkernagel RM. Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. J Immunol. 1994;153:3386-3397.
21. De Milito A, Morch C, Sonnerborg A, Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS. 2001;15:957-964.
22. Banchereau J, Rousset F. Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol. 1992;52:125-262.
23. MacLennan IC, Gulbranson-judge A, Toellner KM. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol Rev. 1997;156:53-66.
24. RajewskyK. Burnet's unhappy hybrid. Nature. 1998;394:624-625.
25. Maurer D, Holter W, Majdic O, Fischer GF, Knapp W. CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol. 1990; 20:2679-2684.
26. Maurer D, Fischer GF, Fae I, et al. IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol. 1992; 148:3700-3705.
27. Agematsu K, Nagumo H, Yang FC, et al. B cellsubpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol. 1997;27:2073-2079.
28. Agematsu K, Hokibara S, Nagumo H, Komiyama A. CD27: a memory B-cell marker. Immunol Today. 2000;21:204-206.
29. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig) M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188:1679-1689.
30. Weller S, Braun MC, Tan BK, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 2004;104:3647-3654.
31. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357:1903-1915.
32. Feng WH, Westphal E, Mauser A, et al. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors. J Virol. 2002;76: 10951-10959.
33. Czerkinsky C, Andersson G, Ekre HP, et al. Reverse ELISPOT assay for clonal analysis of cytokine production: enumeration of gamma-interferon- secreting cells. J Immunol Methods. 1988; 110:29-36.
34. Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme- linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods. 1983;65:109-121.
35. Sedgwick JD, Holt PG. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods. 1983;57:301-309.
36. Fondere JM, Huguet MF, Yssel H, et al. Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy. AIDS. 2003;17:2323-2330.
37. Tuaillon E, Tabaa YA, Petitjean G, et al. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HbsAg) from HbsAg- vaccinated or HBV-immunized subjects by ELISPOT assay. J Immunol Methods. 2006;31: 144-152.
38. Corne P, Huguet MF, Briant L, Segondy M, Reynes J, Vendrell JP. Detection and enumeration of HIV-1-producing cells by ELISPOT (enzyme-linked immunospot) assay. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:442-447.
39. Fondere JM, Petitjean G, Huguet MF, et al. Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals. J Virol. 2004;78:10536-10542.
40. Becquart P, Petitjean G, Al Tabaa Y, et al. Detection of a large T-cell reservoir able to replicate HIV-1 actively in breast milk. AIDS. 2006;20: 1453-1455.
41. Vendrell JP. Peripheral blood naive and memory B cells. In: Lotze MT, Thomson AW, eds. Measuring Immunity: Basic Biology and Clinical Assessment. London, United Kingdom: Elsevier Academic Press; 2004:277-288.
42. Conge AM, Tarte K, Reynes J, et al. Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease. AIDS. 1998;12:1437-1449.
43. Cordoba F, Lavabre-Bertrand T, Salhi SL, et al. Spontaneous monoclonal immunoglobulin-secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma. Br J Haematol. 2000;108:549-558.
44. Brengel-Pesce K, Morand P, Schmuck A, et al. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol. 2002;66:360-369.
45. Schauer E, Webber S, Green M, Rowe D. Surface immunoglobulin-deficient Epstein-Barr virusinfected B cells in the peripheral blood of pediatric solid-organ transplant recipients. J Clin Microbiol. 2004;42:5802-5810.
46. Rose C, Green M, Webber S, et al. Detection of Epstein-Barr virus genomes in peripheral blood B cells from solid-organ transplant recipients by fluorescence in situ hybridization. J Clin Microbiol. 2002;40:2533-2544.
47. Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med. 1999;190:567-576.
48. Johannessen I, Haque T, N+Jie-Jobe J, Crawford DH. Non-correlation of in vivo and in vitro parameters of Epstein-Barr virus persistence suggests heterogeneity of B cell infection. J Gen Virol. 1998;79:1631-1636.
49. Rickinson AB, Finerty S, Epstein MA. Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: origin of transformed cells arising in co-cultures with foetal lymphocytes. Int J Cancer. 1977;19:775-782.
50. Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Influence of EBV on the peripheral blood memory B cell compartment. J Immunol. 2007;179:3153-3160.
51. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity. 1998;9:395-404.
52. Prang NS, Hornef MW, Jäger M, Wagner HJ, Wolf H, Schwarzmann FM. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood. 1997;89:1665-1677.
53. Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A. 2004;101:239-244.
54. Schwarzmann FM, Prang NS, Reichelt B, et al. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. J Gen Virol. 1994;75:1999-2006.
55. Montalvo EA, Cottam M, Hill S, Wang YJ. YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. J Virol. 1995;69:4158-4165.
56. Prang N, Wolf H, Schwarzmann FM. Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1. J Virol. 1995;69:2644-2648.
57. Fumati FB, Zacby V, Quinlivan EB, Kenney S, Pagano JS. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. J Virol. 1994;68:1827-1836.
58. Gutsch DE, Holley Gunthrie EA, Zhang Q, et al. The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 of NF-kappa B. Mol Cell Biol. 1994;14: 1939-1948.
59. Daibata M, Humphreys RE, Sairenji T. Phosphorylation of the Epstein-Barr virus BZLF1 immediate- early gene product ZEBRA. Virology. 1992; 188:916-920.